The Glucagon-like peptide-1 (GLP-1) agonist lixisenatide and its potential role in treating PD. GLP-1 agonists are molecules that are...see more approved for use to treat type 2 diabetes (you may be familiar with brand names like Ozempic and Weygovy). They act by mimicking human gut hormones or incretins to stimulate the release of insulin. Receptors for […]

Read More

Skin Biopsy Update: The latest news re: efficacy and usefulness in Parkinson’s disease diagnosis, now and in the future ...see more A newly published study assessed the ability of a skin biopsy to diagnose Parkinson’s disease (PD) and related disorders and demonstrated that it was very accurate in distinguishing between those who had the disorders and those […]

Read More

Freezing of gait (FOG) is an abnormal gait pattern that can accompany Parkinson’s disease (PD) as well as other parkinsonian...see more disorders in which there are sudden, short, and temporary episodes of an inability to move the feet forward despite the intention to walk. These episodes can significantly  interfere in daily life and can result in falls. Treatments […]

Read More

Gait impairment can be a significant challenge as Parkinson’s disease (PD) advances, with balance problems, frequent falls, and freezing...see more of gait impeding quality of life. Often these challenges do not respond to increased amounts of PD medication or deep brain stimulation (DBS). In recent years, electrical stimulation of the spinal cord has been a research […]

Read More

In 2022, the U.S. House of Representatives introduced the National Plan to End...see more Parkinson’s Act – the first-ever legislation in Congress focusing on curing and preventing Parkinson’s disease (PD) and ensuring quality care for those living with the disease. Unfortunately, the bill did not pass at that time, but […]

Read More

In a recently published...see more study, a team of researchers at Brigham and Women’s Hospital, spearheaded by Drs. Xianjun Dong and Clemens Scherzer, studied an under-explored type of RNA, called circular RNA (circRNA) and its relationship to brain disease. APDA is […]

Read More

Parkinson’s disease (PD) psychosis, which includes hallucinations...see more and delusions, can frequently occur as PD advances. Hallucinations involve seeing, hearing, experiencing or sensing things that are not there. Delusions are false beliefs that are not based in reality, such as thinking that someone is […]

Read More

In a recently published new study, researchers at Johns Hopkins University...see more School of Medicine, led by Dr. Gabsang Lee, developed a new model for testing whether compounds can interfere in the aggregation of alpha-synuclein, thought to be the primary driver of the pathology of Parkinson’s disease (PD). […]

Read More

Exciting Parkinson’s disease (PD) news was announced last week, based on a newly...see more published medical research study. The article reported on the results of using an established test on cerebral spinal fluid to detect abnormal alpha-synuclein as a way of confirming the diagnosis of PD and even diagnosing PD […]

Read More

With more than 3,000 registrants, 25+ speakers, and 20 different sessions, the two-day...see more APDA Virtual Parkinson’s Conference was an important opportunity to bring the PD community together. Designed to educate, empower, and engage attendees, the conference offered an exciting line-up of healthcare experts, personal stories, and energizing activities. Highlights […]

Read More